Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 206

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Loss of CDKN 2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK 4/6 inhibitor PD 0332991 in melanoma cell lines

Open access
Young, Richard J., Waldeck, Kelly, Martin, Claire, Foo, Jung H., Cameron, Donald P., Kirby, Laura, Do, Hongdo, Mitchell, Catherine, Cullinane, Carleen, Liu, Wendy, Fox, Stephen B., Dutton‐Regester, Ken, Hayward, Nicholas K., Jene, Nicholas, Dobrovic, Alexander, Pearson, Richard B., Christensen, James G., Randolph, Sophia, McArthur, Grant A., Sheppard, Karen E. · 2014 · Pigment Cell & Melanoma Research

Abstract

Summary: We have investigated the potential for the p16‐cyclin D‐CDK 4/6‐retinoblastoma protein pathway to be exploited as a therapeutic target in melanoma. In a cohort of 143 patients with primary invasive melanoma, we used fluorescence in situ hybridization to detect gene copy number variations (CNV s) in CDK 4, CCND 1, and CDKN 2A and immunohistochemistry to determine protein expression. CNV s were common in melanoma, with gain of CDK 4 or CCND 1 in 37 and 18% of cases, respectively, and hemizygous or homozygous loss of CDKN 2A in 56%. Three‐quarters of all patients demonstrated a CNV in at least one of the three genes. The combination of CCND 1 gain with either a gain of CDK 4 and/or loss of CDKN 2A was associated with poorer melanoma‐specific survival. In 47 melanoma cell lines homozygous loss, methylation or mutation of CDKN 2A gene or loss of protein (p16INK4A) predicted sensitivity to the CDK 4/6 inhibitor PD 0332991, while RB 1 loss predicted resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/pcmr.12228

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 206

Metadata

Authors
Young, R. J., Waldeck, K., Martin, C., Foo, J. H., Cameron, D. P., Kirby, L., Do, H., Mitchell, C., Cullinane, C., Liu, W., Fox, S. B., Dutton‐Regester, K., Hayward, N. K., Jene, N., Dobrovic, A., Pearson, R. B., Christensen, J. G., Randolph, S., McArthur, G. A., & Sheppard, K. E.
Venue
Pigment Cell & Melanoma Research
Publisher
Wiley
Published
2014-03-06
Volume
27
Issue
4
Pages
590-600
ISSN
  • 1755-1471 (ISSN-L)
  • 1755-148X
OpenAlex
W1985850253
Cited by
206
References
11
FWCI
9.00
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of CDKN 2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK 4/6 inhibitor PD 0332991 in melanoma cell lines. https://app.cochat.ai/papers/10.1111/pcmr.12228
The paper
Young, R. J., Waldeck, K., Martin, C., Foo, J. H., Cameron, D. P., Kirby, L., Do, H., Mitchell, C., Cullinane, C., Liu, W., Fox, S. B., Dutton‐Regester, K., Hayward, N. K., Jene, N., Dobrovic, A., Pearson, R. B., Christensen, J. G., Randolph, S., McArthur, G. A., & Sheppard, K. E. (2014). Loss of CDKN 2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK 4/6 inhibitor PD 0332991 in melanoma cell lines. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.12228

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.